With a busy earnings season about to kick off, now is a great time to review your portfolio holdings and consider some potential moves.
Some New Recommendations to ConsiderJust this morning, we upgraded five new high-yield stocks to�our industry-leading Best Dividend Stocks list. The full details surrounding the upgrades are available here (you’ll need to log into your Premium account to see them), but I’ll share with you the mindset behind these big moves:
The markets are in dire need of a pullback, but we found some names that are actually a bit undervalued. Raising the average yield within your portfolio is a good idea right now. Several of our new picks yield 5% or more. The MLP space is looking attractive again – high yields and relatively low valuations. We have another group of potential upgrades we’re considering as well, we’re just waiting on some better visibility, which we expect to get when these companies�report earnings this month. Time to Ring the Register?An old saying on Wall Street goes “Sell when you can, not when you have to.” I believe this bit of wisdom applies perfectly to today’s markets.
Top Diversified Bank Stocks To Invest In Right Now: Arch Therapeutics Inc (ARTH)
Arch Therapeutics, Inc. (Arch), formerly Almah, Inc., incorporated on September 16, 2009, operates as a life science company developing polymers containing peptides intended to form gel-like barriers over wounds to stop or control bleeding. Arch is a medical device company offering an approach to the rapid cessation of bleeding (hemostasis) and control of fluid leakage (sealant) during surgery and trauma care. Arch�� products are in preclinical development. The first product, AC5, is designed for hemostasis in minimally invasive (laparoscopic) and open surgical procedures.
AC5
AC5 is a synthetic peptide consisting of naturally occurring amino acids. When squirted or sprayed onto a wound, AC5 intercalates into the nooks and crannies of the connective tissue where it builds itself into a physical, mechanical structure. That structure provides a barrier to leaking substances, including blood and other bodily fluids, regardless of type of surgery or, based on early data, clotting ability.
Advisors' Opinion:- [By James E. Brumley]
With each passing day, the opportunity Arch Therapeutics Inc. (OTCBB:ARTH) is presenting to investors gets a little bit clearer... as clear as AC5. What's AC5? It's a hemostasis agent. In other words, it stops post-surgical bleeding. It doesn't do the job quite like anything else out there, though, and that's a good thing for current and/or future ARTH shareholders.
Top 10 Dow Dividend Stocks To Watch For 2014: Intel Corporation(INTC)
Intel Corporation engages in the design, manufacture, and sale of integrated circuits for computing and communications industries worldwide. It offers microprocessor products used in notebooks, netbooks, desktops, servers, workstations, storage products, embedded applications, communications products, consumer electronics devices, and handhelds. The company also provides system on chip products that integrate its core processing functionalities with other system components, such as graphics, audio, and video, onto a single chip. In addition, it offers chipset products that send data between the microprocessor and input, display, and storage devices, including keyboard, mouse, monitor, hard drive, and CD, DVD, or Blu-ray drives; motherboards designed for desktop, server, and workstation platforms, and that has connectors for attaching devices to the bus; and wired and wireless connectivity products consisting of network adapters and embedded wireless cards used to translate and transmit data across networks. Further, the company provides NAND flash memory products primarily used in portable memory storage devices, digital camera memory cards, and solid-state drives; software products comprising operating systems, middleware, and tools used to develop, run, and manage various enterprise, consumer, embedded, and handheld devices; and software development tools that enable the creation of applications. Additionally, it develops computing platforms, which are integrated hardware and software computing technologies designed to offer an optimized solution. The company sells its products principally to original equipment manufacturers, original design manufacturers, PC components and other products users, and other manufacturers of industrial and communications equipment. It has a strategic alliance with Scientific Conservation Inc. Intel Corporation was founded in 1968 and is based in Santa Clara, California.
Advisors' Opinion:- [By vl2014]
Chip behemoth Intel (INTC) holds the top honor for cumulative performance, with a 34.5% advance for the year so far. This not only put it out in front of the Dogs, but also well ahead of all Dow members. The company announced very good news for the June quarter. Specifically, earnings per share came in at $0.55, which was well above our $0.44 estimate and the prior-year tally of $0.39. Intel benefited from its strategy to broaden the reach of its silicon content from data centers to PCs to the ��nternet of Things�� With the rampup of its Baytrail SoC (system on a chip) family, it has expanded into new segments, including devices running Google�� (GOOG) Chrome operating system, and is on track to reach its goal of 40 million tablet computers sold.
- [By Evan Niu, CFA]
This potential adoption curve will be driven by falling prices for capacitive touchscreen display panels, with 2013 expected to be an inflection point. Costs are expected to get cut in half this year, which would inevitably translate into lower retail prices. Intel (NASDAQ: INTC ) will play a role here, using its weight in component supply chains to help push down costs.
- [By Jon C. Ogg]
Intel Corp. (NASDAQ: INTC) was maintained as Neutral but the estimates were lowered due to weak back to school and lack of a holiday cheer, according to Sterna Agee. The price target is $20, versus a $22.98 close.
Top 10 Dow Dividend Stocks To Watch For 2014: Keating Capital Inc (KIPO)
Keating Capital, Inc., incorporated on May 9, 2008, is a business development company. The Company is an externally managed, non-diversified, closed-end management investment company. The Company focuses to invest principally in equity securities, including convertible preferred securities, and other debt securities convertible into equity securities, of primarily non-public United States based companies. Keating Investments, LLC (Keating Investments) serves as the Company�� investment adviser and also provides it with the administrative services necessary for it to operate. Keating Investments is primarily responsible for the selection, evaluation, structure, valuation and administration of the Company�� investment portfolio. As of December 31, 2010, the Company had investments in industries, including technology equipment, consumer products and clean technology. In May 2013, the Company completed the sale of Solazyme Inc.
During the year ended December 31, 2010, the Company made four portfolio company investments, which included investments in NeoPhotonics Corporation (NeoPhotonics); Livescribe, Inc. (Livescribe); Solazyme, Inc. (Solazyme), and MBA Polymers, Inc. (MBA Polymers). NeoPhotonics develops and manufactures photonic integrated circuit based components, modules and subsystems for use in telecommunications networks. Livescribe is a developer and marketer of a mobile, paper-based computing platform, consisting of smartpens, dot paper, smartpen applications, accessories, desktop software, an online community and development tools. Solazyme is engaged in development and commercialization of algal oil and bioproducts for the fuels and chemicals, nutritionals and health sciences markets. MBA Polymers is a manufacturer of recycled plastics sourced from end of life durable goods, such as computers, electronics, appliances and automobiles. The Company focuses to provide capital primarily to micro-cap companies and small-cap companies.
Advisors' Opinion:- [By Helix Investment Research]
In light of recent debates here on Seeking Alpha regarding Keating Capital (KIPO), we had the opportunity to speak with Tim Keating, the company's CEO, to receive his view of the company, as well as answer a variety of questions regarding the company's equity, portfolio, and investment philosophy. Based on our conversation with Mr. Keating, we believe that the market has misunderstood Keating Capital. With a discount to net asset value of over 20%, and with several catalysts set to materialize in the 2nd half, we believe that there is potential for double digit upside in the remainder of 2013 and 2014. Unless otherwise noted, financial statistics and managerial commentary will be sourced from Keating Capital's Q2 2013 earnings release, its Q2 2013 earnings call, its Q2 2013 earnings presentation, its latest 10-Q, or its 2012 10-K, as well as our conversation with Mr. Keating.
- [By Monica Wolfe]
Keating Capital (KIPO)
Over the past week there were four insiders making buys into Keating Capital as the company�� price is sitting near its 52-week low and as the company made a secondary public offering of its stocks.� The insiders making buys during this public offering of common stock were CEO and President Timothy Keating, Director Taylor Simonton, Chief Investment Officer Kyle Rogers and CFO, COO, CCO and Treasurer Frederic Schweiger.
Top 10 Dow Dividend Stocks To Watch For 2014: Bitcoin Collect Inc (BTCC)
Bitcoin Collect Inc, formerly SolPower, Corp., incorporated on July 22, 1996, offers software solutions for the healthcare industry addressing problems with the system involving billing, collections and the lack of adequate medical insurance. The company�� primary product is a software System called MedCare Collect. In July 2014, the Company acquired Good Vibrations Shoes.
Medcare Collect utilizes the technology in electronic banking and transaction submission allowing healthcare professionals to accept clients who may not have adequate health insurance with an almost negligible risk of the patient defaulting. MedCare Collect is revolutionizing medical billing by allowing doctors to take on patients they would otherwise have to turn away, while adding much needed revenue to their bottom line.
Advisors' Opinion:- [By Iampat]
Square 1 Financial (SQBK) and Bitcoin (BTCC) have sort of touched on the accommodations of having a versatile wallet, and it's without a doubt a corner that I think is still in the early phases of its reception bend. Hence, when I discovered that Facebook was concentrating on it, I loved the thought.
Top 10 Dow Dividend Stocks To Watch For 2014: Synalloy Corporation(SYNL)
Synalloy Corporation, together with its subsidiaries, manufactures and sells pipes and piping systems in the United States and internationally. It operates in two segments, Metals and Specialty Chemicals. The Metals segment manufactures pipe and piping systems from stainless steel, carbon, chrome, and other alloys for use in the chemical, petrochemical, pulp and paper, waste water treatment, LNG, mining, power generation, water treatment, brewery, food processing, petroleum, alternative fuels, and pharmaceutical sectors. The Specialty Chemicals segment produces specialty chemicals and dyes for the carpet, chemical, paper, metals, mining, agricultural, fiber, paint, textile, automotive, petroleum, cosmetics, mattress, furniture, janitorial, and other industries. Synalloy Corporation sells its metal products through outside and inside sales employees, manufacturers? representatives, and authorized stocking distributors, as well as directly to engineering firms, construction companies, and project owners. It markets its specialty chemicals directly to various industries through outside sales employees and manufacturers' representatives. The company was formerly known as Blackman Uhler Industries, Inc. and changed its name to Synalloy Corporation in July 1967. Synalloy Corporation was founded in 1945 and is headquartered in Spartanburg, South Carolina.
Advisors' Opinion:- [By GuruFocus]
New Purchase: Synalloy Corporation (SYNL)
Tom Gayner initiated holdings in Synalloy Corporation. His purchase prices were between $13.36 and $16, with an estimated average price of $14.21. The impact to his portfolio due to this purchase was 0.27%. His holdings were 485,343 shares as of 06/30/2013.
Top 10 Dow Dividend Stocks To Watch For 2014: Accretive Health Inc. (AH)
Accretive Health, Inc. provides revenue cycle management services for hospitals and healthcare providers in the United States. It offers integrated revenue cycle management services that help healthcare providers to manage their revenue cycles, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation, and collections; quality and total cost of care services, which enable healthcare providers to manage the health of a defined patient population by identifying those individuals who are most likely to experience an adverse health event; and physician advisory services. Accretive Health, Inc. serves multi-hospital systems, including faith-based or community healthcare systems, academic medical centers, independent ambulatory clinics, and physician practice groups. The company was formerly known as Healthcare Services, Inc. and changed its name to Accretive Health, Inc. in August 2009. Accretive Healt h, Inc. was founded in 2003 and is headquartered in Chicago, Illinois.
Advisors' Opinion:- [By Jon C. Ogg]
Accretive Health Inc. (NYSE: AH) was downgraded to Neutral from Outperform at Credit Suisse.
Beam Inc. (NYSE: BEAM) was downgraded to Hold from Buy based on valuation at Argus.
- [By Laura Brodbeck]
Wednesday
Earnings Expected From: Accretive Health, Inc (NYSE: AH), Monsanto Company (NYSE: MON), UniTek Global Services, Inc. (NASDAQ: UNTK) Economic Releases Expected: Eurozone interest rate decision and PPI data, US National Employment Report, British construction PMIThursday
- [By Jon C. Ogg]
Accretive Health Inc. (NYSE: AH) was downgraded to Perform from Outperform at Oppenheimer.
Alamos�Gold Inc. (NYSE: AGI) was reinstated as Buy with a target price of $21 in Canada, which would translate to closer to $20 in U.S. share prices (versus $16.33 current), at BofA/Merrill Lynch.
Top 10 Dow Dividend Stocks To Watch For 2014: M.D.C. Holdings Inc. (MDC)
M.D.C. Holdings, Inc., through its subsidiaries, engages in homebuilding and financial services businesses in the United States. Its homebuilding business activities include the purchase of finished lots or development of lots for the construction and sale of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name. The company�s financial services business activities comprise the origination of mortgage loans primarily for homebuyers; provision of third-party insurance products to homebuyers; and title agency services to homebuyers in Colorado, Florida, Maryland, Nevada, and Virginia. It also provides insurance coverage on homes sold and for work performed in completed subdivisions; and re-insures the claims. M.D.C. Holdings, Inc. was founded in 1972 and is based in Denver, Colorado.
Advisors' Opinion:- [By Morgan Housel]
Larry Mizel, CEO, MDC Holdings (NYSE: MDC ) :
So I think that the United States is in a unique place where it's a safe haven for capital. As we look around the world, there's not a lot of safe havens. And so housing benefits from the pent-up demand. It benefits from the low interest rates. And the home value and the affordability, as you know that the affordability is well imbalanced, and there seems to be room to run between the cost and what the affordability index would anticipate. And so I think the industry is working hard to expand to meet the demand and the needs of the buyer. We're creating jobs, which is great for our country. We're helping the GDP, which is certainly lacking in many areas. So I think the aggregate impact of providing housing and value is working out very well for everyone.
- [By The Oxen Group]
MDC Holdings (MDC) through its subsidiary Richmond American Homes builds new single family homes in various regions of the country and provides mortgage services as well. We initiate a BUY recommendation as we believe company shares have the potential to appreciate by 50% in the next 12 months. MDC is entering the upscale housing market that, if profitable, could potentially lead the way to further development in this direction. The company could also see a revenue boost and better market share due to implementations of new standard energy features that separates itself from competition.
No comments:
Post a Comment